id: alcohol_use_disorder_to_alcohol_withdrawal_severe
name: Alcohol Use Disorder â†’ Severe Alcohol Withdrawal
from_node:
  node_id: alcohol_use_disorder
  node_name: Alcohol Use Disorder
  node_type: stock
to_node:
  node_id: alcohol_withdrawal_severe
  node_name: Alcohol Withdrawal (Severe) Rate
  node_type: crisis_endpoint
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Chronic heavy alcohol use causes neuroadaptation with downregulated GABA-A receptors and upregulated
  NMDA receptors'
- 'Step 2: Abrupt cessation or reduction removes alcohol''s GABAergic inhibition while excitatory systems
  remain upregulated'
- 'Step 3: Glutamate-mediated hyperexcitability produces autonomic instability, tremor, agitation, and
  seizure risk within 6-24 hours'
- 'Step 4: In 5-10% of cases, withdrawal progresses to delirium tremens (DT) with hallucinations, disorientation,
  and severe autonomic dysfunction'
- 'Step 5: Severe DT manifests as hyperthermia, tachycardia >120, profound confusion, and can be fatal
  without benzodiazepine treatment'
evidence:
  quality_rating: B
  n_studies: 8
  primary_citation: 'S. Leclercq et al.. 2024. "Blood metabolomic profiling reveals new targets in the
    management of psychological symptoms associated with severe alcohol use disorder" eLife. https://doi.org/10.1101/2024.02.27.582239
    (Cited: 5)'
  supporting_citations:
  - 'Wood, Elinore, et al. 2018. "Will this hospitalized patient develop severe alcohol withdrawal syndrome?"
    JAMA 320(8): 825-833. https://doi.org/10.1001/jama.2018.10574'
  - 'Sachdeva, Ankur, et al. 2015. "Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond." Journal
    of Clinical and Diagnostic Research 9(9): VE01-VE07.'
  doi: 10.1111/ane.12671
  citation_verified: true
  needs_manual_review: false
  citation_issues: null
  journal: Acta Neurologica Scandinavica
  year: 2016
  fulltext:
    available: true
    source: pubmed_central
    url: ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ff/47/ANE-135-4.PMC6084325.pdf
    is_open_access: true
    fetched_date: '2025-11-30'
last_updated: '2025-11-30'
version: '1.0'
description: Chronic heavy alcohol use creates neuroadaptation where abrupt cessation triggers severe
  CNS hyperexcitability, manifesting as delirium tremens with autonomic instability and potential mortality.
moderators:
- name: prior_withdrawal_episodes
  direction: strengthens
  strength: strong
  description: Kindling phenomenon makes each subsequent withdrawal episode more severe (neurobiological
    sensitization)
- name: concurrent_benzodiazepine_use
  direction: u_shaped
  strength: moderate
  description: Therapeutic benzodiazepines prevent severe withdrawal; chronic co-dependence complicates
    treatment
- name: medical_comorbidities
  direction: strengthens
  strength: moderate
  description: Infection, trauma, or metabolic disturbances increase DT risk and severity
- name: thiamine_deficiency
  direction: strengthens
  strength: strong
  description: Wernicke encephalopathy can co-occur with withdrawal, increasing neurologic morbidity and
    mortality
structural_competency:
  root_cause_level: institutional
  avoids_victim_blaming: true
  equity_implications: Severe alcohol withdrawal disproportionately affects individuals without stable
    housing, healthcare access, or social support who cannot safely detoxify. People experiencing homelessness
    cycle through untreated withdrawal in emergency departments and jails rather than receiving appropriate
    medical detoxification. The high rate of severe withdrawal in marginalized populations reflects systematic
    failures to provide accessible addiction treatment and social services, not individual choices. Policies
    that criminalize addiction and defund treatment programs directly increase severe withdrawal and associated
    mortality.
assumptions:
- Assumes abrupt cessation after sustained heavy use (>8 drinks/day for weeks to months)
- Withdrawal timeline varies by individual drinking history and metabolism
- Risk stratification assumes no prophylactic benzodiazepine treatment
limitations:
- Only 5-10% of alcohol withdrawal progresses to severe DT
- Mechanism does not account for protective effect of medical supervision and benzodiazepine protocols
- Genetic factors influencing GABA/NMDA receptor regulation create individual variability
spatial_variation:
  varies_by_geography: true
  variation_notes: Severe withdrawal rates vary by access to medical detoxification facilities, harm reduction
    services, and hospital protocols
  relevant_geographies:
  - Rural areas lack detoxification facilities forcing ED-based management
  - Urban safety-net hospitals concentrate uninsured severe withdrawal cases
  - States with Medicaid-funded residential detox show lower severe withdrawal mortality
  - Correctional facilities show high rates due to abrupt forced cessation without adequate medical monitoring
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-11-18T00:00:00'
  extraction_confidence: high
  prompt_version: 1.0-mvp
